| 000 | 01753 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517071859.0 | ||
| 264 | 0 | _c20161031 | |
| 008 | 201610s 0 0 eng d | ||
| 022 | _a1573-9546 | ||
| 024 | 7 |
_a10.1007/s11302-015-9491-2 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aGuzmán-Gutiérrez, Enrique | |
| 245 | 0 | 0 |
_aInsulin requires A1 adenosine receptors expression to reverse gestational diabetes-increased L-arginine transport in human umbilical vein endothelium. _h[electronic resource] |
| 260 |
_bPurinergic signalling _cMar 2016 |
||
| 300 |
_a175-90 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aArginine _xmetabolism |
| 650 | 0 | 4 |
_aCationic Amino Acid Transporter 1 _xbiosynthesis |
| 650 | 0 | 4 |
_aDiabetes, Gestational _xdiet therapy |
| 650 | 0 | 4 |
_aEndothelium, Vascular _xdrug effects |
| 650 | 0 | 4 |
_aEquilibrative Nucleoside Transporter 1 _xmetabolism |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHuman Umbilical Vein Endothelial Cells _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xpharmacology |
| 650 | 0 | 4 | _aInfant, Newborn |
| 650 | 0 | 4 |
_aInsulin _xpharmacology |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPregnancy |
| 650 | 0 | 4 | _aPrimary Cell Culture |
| 650 | 0 | 4 |
_aReceptor, Adenosine A1 _xdrug effects |
| 650 | 0 | 4 |
_aUmbilical Veins _xdrug effects |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aArmella, Axel | |
| 700 | 1 | _aToledo, Fernando | |
| 700 | 1 | _aPardo, Fabián | |
| 700 | 1 | _aLeiva, Andrea | |
| 700 | 1 | _aSobrevia, Luis | |
| 773 | 0 |
_tPurinergic signalling _gvol. 12 _gno. 1 _gp. 175-90 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11302-015-9491-2 _zAvailable from publisher's website |
| 999 |
_c25581483 _d25581483 |
||